Jessica R Allegretti Selected Research

Fecal Microbiota Transplantation

1/2022	Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study.
10/2021	Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
9/2021	Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection.
3/2021	Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity.
1/2021	Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation.
1/2021	Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
1/2021	Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection.
1/2021	Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
1/2021	Fecal Microbiota Transplantation: The Evolving Risk Landscape.
1/2021	Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica R Allegretti Research Topics

Disease

32	Clostridium Infections 01/2022 - 04/2014
14	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021 - 05/2015
11	Ulcerative Colitis 10/2022 - 12/2015
10	Crohn Disease (Crohn's Disease) 10/2022 - 12/2015
8	Infections 01/2022 - 01/2017
3	Diarrhea 12/2019 - 11/2018
2	Necrosis 04/2022 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Pouchitis 10/2021 - 01/2019
2	Obesity 03/2021 - 01/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2021 - 11/2020
2	Chronic Disease (Chronic Diseases) 11/2020 - 01/2020
2	Sclerosing Cholangitis 01/2019 - 01/2019
2	Colitis 10/2016 - 12/2015
1	Vascular Diseases (Vascular Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	COVID-19 01/2021
1	Bacteremia 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Dysbiosis 12/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2019
1	Ileus 05/2019
1	Enteritis 05/2019
1	Disease Progression 05/2019
1	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Abdominal Pain (Pain, Abdominal) 10/2018
1	Pancreatitis 10/2016
1	Chronic Pain 11/2015

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
4	Pharmaceutical PreparationsIBA 10/2022 - 01/2021
4	Ustekinumab (CNTO 1275)FDA Link 10/2022 - 01/2021
4	vedolizumabIBA 04/2022 - 12/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 12/2015
3	Infliximab (Remicade)FDA Link 04/2022 - 01/2020
3	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 10/2019
2	Biological ProductsIBA 04/2022 - 01/2021
2	tofacitinibIBA 04/2022 - 10/2021
2	Phenobarbital (Luminal)FDA Link 01/2022 - 12/2019
2	acceleratory factor from growth hormone (AcG)IBA 01/2022 - 01/2021
2	LigandsIBA 01/2022 - 11/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 10/2016
1	Adalimumab (Humira)FDA Link 04/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	HydrolasesIBA 10/2019
1	Alkaline PhosphataseIBA 01/2019
1	Medical MarijuanaIBA 10/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2016
1	C-Reactive ProteinIBA 12/2015
1	SteroidsIBA 11/2015

Therapy/Procedure

37	Fecal Microbiota Transplantation 01/2022 - 04/2014
14	Therapeutics 01/2022 - 05/2015
5	Transplantation 01/2020 - 01/2017
2	Colectomy 01/2020 - 10/2016
1	Secondary Prevention 12/2019
1	Organ Transplantation 01/2019
1	Antibiotic Prophylaxis 01/2019
1	Biological Therapy 10/2018
1	Patient Readmission 11/2015